Safety and Tolerance of Lactobacillus reuteri in Healthy Adult Male Subjects

Article English OPEN
Wolf, B. W. ; Garleb, K. A. ; Ataya, D. G. ; Casas, I. A. (2011)
  • Publisher: Microbial Ecology in Health and Disease
  • Journal: Microbial Ecology in Health and Disease (issn: 1651-2235)
  • Related identifiers: doi: 10.3402/mehd.v8i2.8264
  • Subject:
    mesheuropmc: food and beverages

Thirty healthy, male subjects (age I8 to 75 yrs) were used in a two-group, double-blinded, parallel design to evaluate the safety and tolerance of a potential probiotic organism, Lactobacillus reuteri. Subjects ( 15/treatment) consumed two gelatin capsules daily for 21 d that contained either a freeze dried L. reuteri preparation in a cryoprotectant, or a placebo (cryoprotectant). The concentration of L. reuteri was such that subjects consumed 1 x 1011 CFU per day. The study was 28 d in length with daily documentation of the presence of gastrointestinal symptoms (nausea, diarrhoea, cramping, distention, flatulence, vomiting, constipation, burping and reflux). In addition, serum chemistries, haematology, urinalysis, urinary indican excretion, and faecal microbiota (L. reuteri and total Lactobacillus spp. enumeration) were measured weekly (day 0, 7, 14, 21 and 28). A physical exam was given on day 0. 21, and 28. An additional faecal sample was obtained on day 77 for microbial enumeration. Subjects could consume their regular diets; however, alcohol was not allowed. Physical exam and urinalysis parameters were not clinically direrent between treatments. Supplemental L. reuteri reduced (P<0.05) urinary indican excretion at day 7, but had no effect (P>0.05) on subsequent urine collections. Although significant differences were observed for a few of the serum chemistry and haematology variables, all of the d u e s remained within the expected normal range for healthy adult males. Subjects consuming supplemental L. reuteri ad increased (P<0.05) between treatments; however, the ratio of L. reuteri: total Lactobacillus spp. increased (P<0.05) for subjects consuming supplemental L. reuteri. Incidence of subjective tolerance factors was infrequent and similar for both treatments. In conclusion, supplemental L. reuteri may be fed at 1 x 1011 CFU/day without any clinically significant safety or tolerance problems. Intake of L. reuteri (1 x 1011 CFU/day) results in colonisation (as measured by faecal level) within 7 d of consumption and is maintained for at least 7 d post consumption; however, colonisation is lost within 2 mths of washout.Keywords: Lactobacillus reuteri; safety and tolerance; faecal lactobacilli level.
  • References (26)
    26 references, page 1 of 3

    Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. (1989). Production of a broad spectrum antimicrobial substance by Luctobucillus rcwtrri.

    Microbial Ecology in Heulth tind Distwsc~ 2, 131-136.

    Chung TC, Axelsson LT, Lindgren SE, Dobrogosz WJ. (1989). In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial Ew1og.v ir7 Hctrltli and Disease 2, 137-144.

    Collins F M , Carter PB. (1978). Growth of Sulriwnelh in orally infected germfree mice. Inf>c.tioricrnd Immunity 21; 4 1 4 7 . -

    4. Conway P. Kjelleberg S . ( I 989). Protein-mediated adhesion of Luctobacillus fermenturn strain 737 to mouse stomach squamous epithelium. Journal 0 / Generul Micmbiology 135, 1175-1 186.

    5. Dobrogosz WJ. Dunham HJ, Edens FW. Casas IA. ( 1992). Lactobacillus reuteri immunomodulation of stressor-associated diseases in neonate chickens and turkeys. Microbial Ecology in Heulth und Disease 2, VII-VIII.

    6. Edens FW. Parkhurst CR, Casas IA. (1991). Lactohcicillus reuteri feeding elevates levels of blood constituents, hematocrit and hemoglobin in chicks and poults. Poultq. Science 70, 37.

    7 . Edens FW, Parkhurst CR, Casas IA. (1992). GaiaFeedTM supplementation t o market turkeys improves performance. Poulyv Science 71, 4.

    8. Fabia R. AiRajab A, Johansson M-L, Willen R, A n d e r s o n R , Molin G, Bengrnark S. (1993). The effect of exogenous administration of Luctobucillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scandinuvian Jozirnal qf Gastroeriterolog~28, 155-162.

    9. Gilliland SE. (1989). Acidophilus milk products: A review of potential benefits to consumers. Jourriul qf Dai1.j~Science 12, 2483-2494.

  • Metrics
    No metrics available
Share - Bookmark